TrialFrontiers in immunology2025

Immunogenicity and safety of a multi-human dose formulation of Biological E's 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14

Subhash Thuluva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.